sec filing
CA
NASDAQ · CABA
Cabaletta Bio, Inc.
Healthcare · Biotechnology
$2.08
Down-$0.06 (-2.88%)
Updated Oct 6, 2026, 10:35 PM
SID Score
2.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 227.19M
- P/E ratio
- -1.52
- Dividend yield
- 0.00%
- 52-week range
- $1.83 – $4.23
- Volume
- 5.41M
- Avg. volume
- 4.22M
Price performance · CABA
CABA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
CABA closed at $2.08 after 20 trading sessions, down 36.39% for the selected period.
- Last close
- $2.08
- Period change
- -36.39%
- Period low
- $1.89
- Period high
- $3.27
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $2.01 | $2.12 | $1.955 | $2.08 | 5.41M |
| Oct 2, 2026 | $1.94 | $2.01 | $1.83 | $2.00 | 5.71M |
| Oct 1, 2026 | $1.92 | $1.97 | $1.86 | $1.89 | 8.54M |
| Sep 30, 2026 | $2.01 | $2.01 | $1.90 | $1.92 | 8.05M |
| Sep 29, 2026 | $2.01 | $2.03 | $1.95 | $1.98 | 4.19M |
| Sep 28, 2026 | $2.06 | $2.07 | $1.98 | $2.00 | 5.44M |
| Sep 25, 2026 | $2.17 | $2.17 | $2.05 | $2.07 | 3.1M |
| Sep 24, 2026 | $2.23 | $2.23 | $2.06 | $2.155 | 5.59M |
| Sep 23, 2026 | $2.53 | $2.56 | $2.19 | $2.22 | 8.68M |
| Sep 22, 2026 | $2.48 | $2.60 | $2.46 | $2.50 | 5.31M |
| Sep 21, 2026 | $2.64 | $2.65 | $2.45 | $2.46 | 4.73M |
| Sep 18, 2026 | $2.55 | $2.61 | $2.52 | $2.55 | 12.48M |
| Sep 17, 2026 | $2.52 | $2.59 | $2.50 | $2.58 | 4.26M |
| Sep 16, 2026 | $2.65 | $2.68 | $2.48 | $2.49 | 6.14M |
| Sep 15, 2026 | $2.89 | $2.92 | $2.57 | $2.595 | 7.24M |
| Sep 14, 2026 | $2.72 | $3.04 | $2.71 | $2.91 | 6.31M |
| Sep 11, 2026 | $2.77 | $2.886 | $2.67 | $2.73 | 7.44M |
| Sep 10, 2026 | $2.85 | $2.875 | $2.69 | $2.74 | 7.08M |
| Sep 9, 2026 | $3.28 | $3.28 | $2.90 | $2.91 | 6.51M |
| Sep 8, 2026 | $3.43 | $3.48 | $3.26 | $3.27 | 3.07M |
Latest CABA news
The latest Smart Investors Daily articles mentioning CABA.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…